BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2984616)

  • 1. Amenorrhea and endometrial atrophy with continuous oral estrogen and progestogen therapy in postmenopausal women.
    Magos AL; Brincat M; Studd JW; Wardle P; Schlesinger P; O'Dowd T
    Obstet Gynecol; 1985 Apr; 65(4):496-9. PubMed ID: 2984616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestogen therapy in postmenopausal women.
    Leather AT; Savvas M; Studd JW
    Obstet Gynecol; 1991 Dec; 78(6):1008-10. PubMed ID: 1658699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate.
    Odmark IS; Jonsson B; Bäckström T
    Am J Obstet Gynecol; 2001 May; 184(6):1131-8. PubMed ID: 11349178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
    Archer DF; Pickar JH; Bottiglioni F
    Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and metabolic responses of menopausal women to sequential versus continuous estrogen and progestin replacement therapy.
    Luciano AA; Turksoy RN; Carleo J; Hendrix JW
    Obstet Gynecol; 1988 Jan; 71(1):39-43. PubMed ID: 2827082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Continuous postmenopausal estrogen-progesterone therapy].
    Affinito P; Tommaselli GA; Morgera R; Rinaldi M; Di Mauro P; Nappi C
    Minerva Ginecol; 1993 Mar; 45(3):77-85. PubMed ID: 8392669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
    Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
    Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
    Johannisson E; Holinka CF; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of estrogens and progestogens on the endometrium. Modern approach to treatment.
    Whitehead MI; Fraser D
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):299-320. PubMed ID: 3306523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding patterns in peri and postmenopausal women taking a continuous combined regimen of estradiol with norethisterone acetate or a conventional sequential regimen of conjugated equine estrogens with medrogestone.
    von Holst T; Lang E; Winkler U; Keil D
    Maturitas; 2002 Dec; 43(4):265-75. PubMed ID: 12468135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of a monophasic continuous estro-progestogenic treatment on Latin American menopausal women.
    Bassol S; Carranza-Lira S; Celis-Gonzalez C; Santoyo S; Murillo A; Martinez N; Santos J; Llaca V; de la Loza FR; Zarain J; da Fonseca AM; Camargos AF; Baracat EC; da Sá MF; Bayo J; Adaro L; Gurucharri C; Murga M; Siseles N; Sayegh F; Tempone A; Tempone LM; Tozzini RI; Boccanera R; Naranjo C; Sanchez F; Gomez G; Blanco S; Reyes-Marquez R; Albrecht G; Rios PC
    Maturitas; 2005 Mar; 50(3):189-95. PubMed ID: 15734600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial pathology and estrogens.
    Rosenwaks Z; Wentz AC; Jones GS; Urban MD; Lee PA; Migeon CJ; Parmley TH; Woodruff JD
    Obstet Gynecol; 1979 Apr; 53(4):403-10. PubMed ID: 220573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial histology and bleeding patterns in menopausal women treated with estrogen and continuous or cyclic progestin.
    Bewtra C; Kable WT; Gallagher JC
    J Reprod Med; 1988 Feb; 33(2):205-8. PubMed ID: 2832598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous combined conjugated equine estrogen-progestogen therapy: effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis.
    Hillard TC; Siddle NC; Whitehead MI; Fraser DI; Pryse-Davies J
    Am J Obstet Gynecol; 1992 Jul; 167(1):1-7. PubMed ID: 1442905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
    Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
    Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role and use of progestogens.
    Whitehead MI; Hillard TC; Crook D
    Obstet Gynecol; 1990 Apr; 75(4 Suppl):59S-76S; discussion 81S-83S. PubMed ID: 2179792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.